Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Antonio Nino"'
Autor:
Adriana M. Montaño, Agnieszka Różdżyńska-Świątkowska, Agnieszka Jurecka, Antonio Nino Ramirez, Lin Zhang, Deborah Marsden, Raymond Y. Wang, Paul Harmatz
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 36, Iss , Pp 100987- (2023)
Objective: This study assessed growth patterns in patients with mucopolysaccharidosis (MPS) VII before enzyme replacement therapy. Methods: Height, weight, and body mass index (BMI) measurements and Z-scores from patients from three clinical studies
Externí odkaz:
https://doaj.org/article/68199889bc9745e98000b49f745e7638
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-3 (2021)
Abstract It has recently been suggested that registries for rare neuromuscular diseases should be formed and governed exclusively by physicians and patients in an effort to limit conflicts of interest. Enacting such an approach would not only be chal
Externí odkaz:
https://doaj.org/article/2a91e3dfeaad46499ad48404ad595a09
Autor:
Qian Chen, Chaoying Hu, Yanmei Liu, Rong Song, Wenjing Zhu, Hongxin Zhao, Antonio Nino, Fan Zhang, Yun Liu
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197984 (2018)
BACKGROUND:Denosumab is a fully human monoclonal antibody against receptor activator of nuclear factor kappa-B ligand, a cytokine essential for the formation, function and survival of osteoclasts. This study assessed the pharmacokinetics, pharmacodyn
Externí odkaz:
https://doaj.org/article/c3529daa0b4b42af907685b5e28884f3
Autor:
Vaswani, Kapil, Volos, Stavros, Fournet, Cédric, Diaz, Antonio Nino, Gordon, Ken, Vembu, Balaji, Webster, Sam, Chisnall, David, Kulkarni, Saurabh, Cunningham, Graham, Osborne, Richard, Wilkinson, Dan
We present IPU Trusted Extensions (ITX), a set of experimental hardware extensions that enable trusted execution environments in Graphcore's AI accelerators. ITX enables the execution of AI workloads with strong confidentiality and integrity guarante
Externí odkaz:
http://arxiv.org/abs/2205.09005
Autor:
Montaño, Adriana M., Różdżyńska-Świątkowska, Agnieszka, Jurecka, Agnieszka, Ramirez, Antonio Nino, Zhang, Lin, Marsden, Deborah, Wang, Raymond Y., Harmatz, Paul
Publikováno v:
In Molecular Genetics and Metabolism Reports September 2023 36
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jerry, Vockley, Gregory M, Enns, Antonio Nino, Ramirez, Camille L, Bedrosian, Bridget, Reineking, Xiaoxiao, Lu, Kathryn, Ray, Syeda, Rahman, Deborah, Marsden
Publikováno v:
Molecular Genetics and Metabolism. 136:152-162
Long-chain fatty acid oxidation disorders (LC-FAOD) are a group of inborn errors of metabolism wherein patients are unable to process long-chain fatty acids into useable energy in the mitochondria. LC-FAOD commonly affects organ systems with high ene
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Julio Rosenstock, Jason M. Mallory, Joseph Soffer, Molly C. Carr, Antonio Nino, Jo F. Dole, Andre Acusta, Lois M. Erskine, Philip Home
Publikováno v:
Diabetes Care. 43:2509-2518
OBJECTIVE The principle of replacing prandial insulin lispro with a once-weekly glucagon-like peptide 1 receptor agonist (GLP-1RA) for type 2 diabetes inadequately controlled on a multiple daily insulin injections regimen was tested with albiglutide.
Autor:
David M. Roth, Deborah M. Levy, Michael Henrickson, Inmaculada Calvo Penades, Carlos Abud-Mendoza, Michael Shishov, Vyacheslav Chasnyk, Julia E Calderon, Antonio Nino, Diego O Viola, Alina Boteanu, Manuel A. Ferrandiz, Maria Gastanaga, Herbert Struemper, Mei-Lun Wang, Anne E. Hammer, Kenneth L. Clark, Hermine I. Brunner, Beulah Ji, Vladimir Keltsev, Nicolino Ruperto, Daniel J. Lovell, Jordi Anton, Damon Bass, Alberto Martini
Publikováno v:
Annals of the Rheumatic Diseases
ObjectivesThis ongoing Phase-2, randomised, placebo-controlled, double-blind study evaluated the efficacy, safety and pharmacokinetics of intravenous belimumab in childhood-onset systemic lupus erythematosus (cSLE).MethodsPatients (5 to 17 years) wer